Evidence map›Paper›PMID 25348604›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2015

Early social enrichment rescues adult behavioral and brain abnormalities in a mouse model of fragile X syndrome.

Diego Oddi, Enejda Subashi, Silvia Middei, Luigi Bellocchio, Valerie Lemaire-Mayo, Manuel Guzmán, Wim E Crusio, Francesca R D'Amato, Susanna Pietropaolo

Open access · bronzeAbstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 1 pooled it
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 1 synthesis or guideline pooled it, 104 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Therapeutic efficacy of the BKCa channel opener chlorzoxazone in a mouse model of Fragile X syndrome.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Article
  10. Article
  11. Review
  12. Article
  13. Hyperacusis in the AdultInternational journal of molecular sciences · 2023
    Article
  14. The Impact of Mild Chronic Stress and Maternal Experience in theInternational journal of molecular sciences · 2023
    Article
  15. Mouse models of fragile X-related disorders.Disease models & mechanisms · 2023
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 3 countries.

Diego Oddi1] CNR, Cell Biology and Neurobiology Institute, Rome, Italy [2] IRCCS, Santa Lucia Foundation, Rome, Italy.
Enejda Subashi1] Université Bordeaux, INCIA, Talence, France [2] CNRS, INCIA, UMR5287, Talence, France.
Silvia Middei1] CNR, Cell Biology and Neurobiology Institute, Rome, Italy [2] IRCCS, Santa Lucia Foundation, Rome, Italy.
Luigi BellocchioDepartment of Biochemistry and Molecular Biology I, School of Biology, Complutense University and CIBERNED, Madrid, Spain.
Valerie Lemaire-Mayo1] Université Bordeaux, INCIA, Talence, France [2] CNRS, INCIA, UMR5287, Talence, France.
Manuel GuzmánDepartment of Biochemistry and Molecular Biology I, School of Biology, Complutense University and CIBERNED, Madrid, Spain.
Wim E Crusio1] Université Bordeaux, INCIA, Talence, France [2] CNRS, INCIA, UMR5287, Talence, France.
Francesca R D'Amato1] CNR, Cell Biology and Neurobiology Institute, Rome, Italy [2] IRCCS, Santa Lucia Foundation, Rome, Italy.
Susanna Pietropaolo1] Université Bordeaux, INCIA, Talence, France [2] CNRS, INCIA, UMR5287, Talence, France.
Université de Bordeaux · FRInstitute of Cell Biology and Neurobiology · ITBiomedical Research Networking Center on Neurodegenerative Diseases · ESFondazione Santa Lucia · ITInstitut de Neurosciences Cognitives et Intégratives d’Aquitaine · FRUniversidad Complutense de Madrid · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Converging lines of evidence support the use of environmental stimulation to ameliorate the symptoms of a variety of neurodevelopmental disorders. Applying these interventions at very early ages is critical to achieve a marked reduction of the pathological phenotypes. Here we evaluated the impact of early social enrichment in Fmr1-KO mice, a genetic mouse model of fragile X syndrome (FXS), a major developmental disorder and the most frequent monogenic cause of autism. Enrichment was achieved by providing male KO pups and their WT littermates with enhanced social stimulation, housing them from birth until weaning with the mother and an additional nonlactating female. At adulthood they were tested for locomotor, social, and cognitive abilities; furthermore, dendritic alterations were assessed in the hippocampus and amygdala, two brain regions known to be involved in the control of the examined behaviors and affected by spine pathology in Fmr1-KOs. Enrichment rescued the behavioral FXS-like deficits displayed in adulthood by Fmr1-KO mice, that is, hyperactivity, reduced social interactions, and cognitive deficits. Early social enrichment also eliminated the abnormalities shown by adult KO mice in the morphology of hippocampal and amygdala dendritic spines, namely an enhanced density of immature vs mature types. Importantly, enrichment did not induce neurobehavioral changes in WT mice, thus supporting specific effects on FXS-like pathology. These findings show that early environmental stimulation has profound and long-term beneficial effects on the pathological FXS phenotype, thereby encouraging the use of nonpharmacological interventions for the treatment of this and perhaps other neurodevelopmental diseases.

Indexed as

Social BehaviorAnimalsBrainCognitionCohort StudiesDendritic SpinesDisease Models, AnimalFragile X Messenger Ribonucleoprotein 1Fragile X SyndromeFreezing Reaction, CatalepticLocomotionMaleMaternal BehaviorMaternal DeprivationMice, KnockoutTreatment OutcomeFmr1 protein, mouseFragile X Messenger Ribonucleoprotein 1

Identifiers

PMID25348604
PMCPMC4367453
OpenAlexW2001265236

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.